Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Initiation in Japanese Patients with Asthma Previously on Inhaled Corticosteroid/Long-Acting β<sub>2</sub>-Agonist Therapy: A Retrospective Cohort Study.

J Clin Med · 2025 · PMC12028120 · PMID 40283397

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

Both subgroups showed a trend for reduction in both OCS and SABA use from baseline to follow-up, although some outcomes did not reach statistical significance ( Table 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Initiation in Japanese Patients with Asthma Previously on Inhaled Corticosteroid/Long-Acting β&lt;sub&gt;2&lt;/sub&gt;-Agonist Therapy: A Retrospective Cohort Study.

The sentences

Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Initiation in Japanese Patients with Asthma Previously on Inhaled Corticosteroid/Long-Acting β<sub>2</sub>-Agonist Therapy: A Retrospective Cohort Study.